Innovative Eyewear Inc

Overview

Compare with RxSight, Inc., STAAR SURGICAL CO or Warby Parker, or pick any stock.

• TickerLUCY on Nasdaq¹
• IndustryOphthalmic Goods¹
• HeadquartersMiami, Florida¹
• Incorporated inFL²
• Business address11900 Biscayne Blvd, Ste 630, Miami, Fl 33181²
• Filer category, Emerging growth company²

See how the biggest companies compare on our leaderboards

We develop and sell cutting-edge smart eyewear – including prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses – that is designed to allow our customers to remain connected to their digital lives.³ From its latest annual report

Corporate structure

Innovative Eyewear Inc sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Innovative Eyewear Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Intangibles and goodwill

Inventory

Properties, in its own words

Our executive offices are located at 11900 Biscayne Blvd., Suite 630, North Miami, Florida 33181. Our executive offices are provided to us by Tekcapital, who bills us for an allocation of rent paid by Tekcapital on our behalf. This arrangement does not have a specific end date, and can be terminated with 30 calendar days written notice by any party. We consider our current office space adequate for our current operations.

Item 2 of the 10-K filed Mar 25, 2026.³

Leadership

Who has led Innovative Eyewear Inc, and when. Pick a name to see everywhere that person has worked.

• Chief executive officerHarrison R. Gross Aug 15, 2022 to now¹⁰
• Chief financial officerKonrad Dabrowski Aug 15, 2022 to Dec 19, 2023¹¹
• Chief operating officerJoaquin Abondano Jan 18, 2024 to now¹²

Timeline

1. Oct 15, 20268-K Listing notice or transfer¹⁸
2. Oct 8, 20268-K Results of operations¹⁹
3. Jul 9, 20268-K Entered a material agreement; Unregistered sale of shares; Other events²⁰
4. Jan 7, 20268-K Results of operations²¹
5. Nov 7, 20258-K Executive or director change²²
6. Oct 29, 20258-K Shareholder vote²³
7. Oct 16, 20258-K Shareholder vote²⁴
8. Aug 28, 20258-K Shareholder vote²⁵
9. Aug 15, 20258-K Other events²⁶
10. Jun 30, 20258-K Director nominations²⁷
11. Jun 24, 20258-K Entered a material agreement; Unregistered sale of shares; Other events²⁸
12. Apr 15, 20258-K Entered a material agreement; Unregistered sale of shares; Other events²⁹
13. Aug 15, 2022New chief executive Harrison R. Gross becomes CEO¹⁰

Calendar

Coming up

1. Nov 12, 2026Reports results for the quarter ending Sep/2026³⁰

When it reported results

1. Oct 8, 2026Reported quarterly or annual results¹⁹
2. Jan 7, 2026Reported quarterly or annual results²¹

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

245 filings to the SEC since October 2021: 4 annual reports, 13 quarterly reports, 35 major events, 52 insider forms, 21 large holders, 120 other. The latest 20:

1. Oct 15, 20268-K EDGAR
2. Oct 8, 20268-K EDGAR
3. Oct 5, 2026DEF 14A EDGAR
4. Sep 24, 2026PRE 14A EDGAR
5. Sep 21, 2026144 EDGAR
6. Aug 25, 2026144 EDGAR
7. Aug 24, 2026144/A EDGAR
8. Aug 24, 20264 EDGAR
9. Aug 24, 20264 EDGAR
10. Aug 24, 20264 EDGAR
11. Aug 24, 20264 EDGAR
12. Aug 24, 20264 EDGAR
13. Aug 20, 2026144 EDGAR
14. Aug 20, 2026144 EDGAR
15. Aug 19, 2026144 EDGAR
16. Aug 19, 2026144 EDGAR
17. Aug 19, 2026144 EDGAR
18. Aug 14, 202610-Q EDGAR
19. Aug 7, 2026EFFECT EDGAR
20. Jul 23, 2026S-1 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

69 open-market trades by officers, directors and large owners since October 2021: 31 buys and 38 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• INTRACOASTAL CAPITAL, LLCSCHEDULE 13G/A, 8 filings Jun 30, 2023 to May 13, 2026³¹
• Kelly Joseph ChapmanSCHEDULE 13G/A, 2 filings Jan 22, 2026 to Feb 5, 2026³²
• Vladimir GalkinSCHEDULE 13D/A, 11 filings Sep 23, 2024 to Jan 7, 2026³³

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Innovative Eyewear Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARInnovative Eyewear Inc¹
• CIK0001808377
• Employer ID (EIN)85-0734861³
• Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company³
• Incorporated inFlorida³
• Fiscal year endsDecember 31¹
• Industry code (SIC)3851 Ophthalmic Goods¹
• SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance¹
• Business address11900 Biscayne Blvd, Ste 630, Miami, FL 33181¹
• Mailing address66 W Flagler St. Suite 900, Ste 216, Miami, FL 33130¹
• Phone786-910-1898¹
• Shares outstanding8,609,196 as of Aug 11, 2026⁹
• Public float$7.0M as of Jun 30, 2025³
• AuditorCherry Bekaert LLP, Chicago, Illinois PCAOB ID 677; no auditor attestation of internal control over financial reporting³
• On EDGAR sinceJun 29, 2020¹
• Filings259 in all: 8-K (35), 4 (30), 144 (26), CORRESP (19), 10-Q (13), S-1/A (13), 3 (11), UPLOAD (11)¹
  All 39 form types

  EFFECT (9), C/A (8), S-1 (8), 424B5 (7), 144/A (6), SC 13D/A (6), 4/A (5), 5 (5), SCHEDULE 13G/A (5), 10-K (4), DEF 14A (4), SCHEDULE 13D/A (4), C-U (3), PRE 14A (3), 424B4 (2), C (2), DEFA14A (2), DRS (2), S-8 (2), SC 13G (2), SCHEDULE 13G (2), 3/A (1), 424B3 (1), 8-A12B (1), C-AR (1), C-AR/A (1), CERT (1), S-3 (1), S-3/A (1), SC 13D (1), SC 13G/A (1)

• Latest filingsAnnual report (10-K) Mar 25, 2026
  Quarterly report (10-Q) Aug 14, 2026
  Proxy statement (DEF 14A) Oct 5, 2026
  Latest 8-K (8-K) Oct 15, 2026

Securities registered for trading

From the cover page of the 10-K filed Mar 25, 2026 (Section 12(b) of the Exchange Act).³

Risk factors and legal proceedings

The risks Innovative Eyewear Inc names in Item 1A of its 10-K filed Mar 25, 2026: 40 risks under these headings, as written.³

• Risks Related to our Business, Strategy and Industry
• Risks Related to our Intellectual Property
• Risks Related to Our Dependence on Third Parties
• Risks Relating to Our Business, Strategy and Industry
• Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our securities.
• The optical industry is highly competitive, and if we do not compete successfully, our business may be adversely impacted.
• We have a history of losses, and we may be unable to achieve or sustain profitability.
• We have limited experience in the smart eyewear space. If we are unable to manage our growth effectively, our brand and our financial performance may suffer, which may have a material adverse effect on our business, financial condition, and operating results.
• We currently derive principally all of our revenue from sales of our glasses and lenses. A decline in sales of our eyewear would negatively affect our business, financial condition, and results of operations.
• Our ability to generate net revenue will depend upon many factors, some of which we may have no control over.
• Increases in component costs, shipping costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and factors such as wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.
• We face significant risks due to our dependency on foreign supply and manufacturing chains, geopolitical and economic changes, and changes in public perception about internationally sourced and manufactured products.

Legal proceedings

We are not currently the subject of any material pending legal proceedings; however, we may from time to time become a party to various legal proceedings arising in the ordinary course of business.

The opening of Item 3, Legal Proceedings.³